Feb 18, 2020, 13:52 by

Feb 18, 2020, 13:52 by

Greenphire, the global leader in financial software for clinical trials, today announced that it has teamed with top industry sponsor, Roche (SIX: RO, ROG;OTCQX: RHHBY), to address the top hurdles patients face when participating in clinical trials. T

Feb 18, 2020, 08:45 by User Not Found

Clinical Research News| ORLANDO--IBM Watson Health today unveiled its newest cloud-based technology, IBM Study Advance, at the 11th Annual Summit for Clinical Ops Executives (SCOPE) in Orlando, Florida. The data-driven study design and authoring tool optimizes clinical trial protocol design by merging automated access to real-world patient population data, standardizing protocol template guidance and providing a collaborative workspace designed to facilitate efficiency.

Feb 17, 2020, 08:55 by User Not Found

Clinical Research News | Five years ago, phage therapy was a largely unknown approach to treating recalcitrant bacterial infections outside of Eastern Europe. But headline-grabbing stories of bacteriophages bringing people back from the brink of death has catalyzed interest in the century-old practice of using viruses to infect and kill disease-causing bacteria—especially now antimicrobial resistance has limited the usefulness of many antibiotics.

Feb 13, 2020, 12:25 by User Not Found

Clinical Research News | To fully appreciate the potential of Adaptive Phage Therapeutics (APT), it’s helpful to review history through the lens of company co-founder and Chief Scientific Officer Carl Merril. For nearly five decades, Carl has been championing the idea of using bacteriophages to treat infectious diseases—an idea for which he has been variably applauded, questioned, ignored, scolded, and, ultimately, vindicated.

Feb 13, 2020, 10:54 by

OWEAR Founders Shimmer, GGIR software and algorithms author Dr. Vincent van Hees, and Nextbridge Health are now joined by non-profits Sage Bionetworks and DiMe. 

Feb 12, 2020, 09:23 by User Not Found

Clinical Research News | Perhaps no academic institution has worked longer on the clinical application of phages than Yale University where research efforts are focused on using the pathogen-fighting viruses to re-sensitize bacteria to the antibiotics they’ve grown resistant to. “We’re hoping to drive evolution in the other direction to preserve our antibiotic arsenal for longer,” says Benjamin Chan, Ph.D., associate research scientist in the department of ecology and evolutionary biology, who maintains a large natural-phage library.

Feb 11, 2020, 14:42 by

Feb 11, 2020, 11:18 by User Not Found

Clinical Research News | At least three different types of phage products currently exist, and all of them are being explored as potential therapeutic remedies for people with drug-resistant bacterial infections. These include natural phages that have not been modified at all, as well as genetically engineered phages where one or more of their genes get modified to optimize their killing potential against a pathogen.

Feb 10, 2020, 10:25 by

Accumen relocates its company headquarters to Phoenix, joining the influx of innovative businesses moving to the Valley of the Sun.

Feb 10, 2020, 10:25 by

Certara’s D360 platform enables Arvinas to accelerate lead identification and optimization processes for oncology, neurodegenerative diseases, and therapies for “undruggable” targets.

Feb 10, 2020, 09:51 by User Not Found

Clinical Research News | A resurgence of interest in phages over the past few years—in basic and translational research, as well as animal agriculture and aquaculture—is closely tied to the global rise in antimicrobial resistance, rendering once-standard treatments ineffective. In the newly declared “post-antibiotic era,” more than 35,000 people in the U.S. are dying each year from a drug-resistant superbug.

Feb 5, 2020, 07:34 by User Not Found

Clinical Research News | A newly FDA approved acne treatment was developed and supported by Simcyp, a division of Certara that used their Simcyp Population-based Simulator to expedite and inform drug development, while also providing safety label claim and pediatric dosing information without the need for testing in clinical patients.

Feb 4, 2020, 15:58 by

3DR Labs will employ Resonance Health’s FerriSmart® software to analyze liver iron concentrations from MRIs and provide summary reports.

Feb 4, 2020, 11:05 by User Not Found

Clinical Research News |Researchers at Brigham & Women’s Hospital (BWH), in partnership with data analytics company Aetion, have been working on a real-world data (RWD) pilot project under the umbrella of RCT DUPLICATE since May 2018 with the financial and leadership support of the U.S. Food and Drug Administration (FDA). The project’s initial goal expanded last April from replicating to predicting results of randomized controlled trials (RCTs) using health insurance claims data.

Feb 4, 2020, 10:56 by User Not Found

Clinical Research News | Clinical trial stakeholders, most notably the U.S. Food and Drug Administration (FDA), continue to grapple with how to harness the value of real-world data (RWD) and real-world evidence (RWE) for demonstrating product effectiveness. Draft guidance expected to be issued by the end of 2021 should shed light on the three key issues outlined in the agency’s Framework for FDA’s Real-World Evidence Program.

Jan 31, 2020, 11:28 by User Not Found

Clinical Research News | Cereval’s Head of Clinical Operations discusses ways to improve the way clinical trials are run, potential barriers to running patient-centric trials, and more.

Jan 30, 2020, 11:02 by User Not Found

Clinical Research News | January was full of exciting news in the clinical trial and healthcare community, including partnerships, products, and promotions from LabCorp, Medial EarlySign, Color, and more.

Jan 29, 2020, 12:09 by User Not Found

Clinical Research News Brief | The Department of Justice announced this week that Practice Fusion will pay $145 million to resolve criminal and civil investigations relating to its electronic health records software.

Jan 28, 2020, 13:46 by User Not Found

Clinical Research News | A virtual randomized trial launching this month will investigate whether a collaboration between a new heart health app, a medication adherence program, and an Apple Watch can accelerate the diagnosis of cardiovascular events, increase healthful lifestyles, and decrease strokes and death rates, all at one percent the cost of traditional clinical trials.